Survival impact of anti-CD38-based quadruplet regimens in transplant-ineligible newly diagnosed multiple myeloma: a network meta-analysis and reconstructed individual patient data meta-analysis.

Blood Cancer J · 2025 · PMC12681503 · PMID 41353340

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceP = 0.06so close (0.05 < p ≤ 0.1)

showed a trendno p-value reported

When compared with D-Rd, both regimens showed a trend toward improved OS; however, these differences did not reach statistical significance (HR 0.69; 95% CI, 0.47–1.03; P = 0.06, and HR 0.76; 95% CI, 0.57–1.02; P = 0.06, respectively).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.